Glaxo Inc. v. Novopharm Ltd.

This document cites

• Federal Cases - Syntex Ophthalmics, Inc. v. Tsuetaki
• Federal Cases - National Polymer Products, Inc. v. Borg-Warner Corp.
• Federal Cases - PepsiCo, Inc. v. Redmond
• Federal Cases - Eli Lilly and Company v. Medtronic, Inc
• Federal Cases - Conroy v. Reebok Intern., Ltd.



See all quotations

• Federal Cases - Telectronics Pacing Systems, Inc. v. Ventritex, Inc.
• Federal Cases - Glaxo Inc. v. Novopharm Ltd., 94-1026
• Federal Cases - Bristol-Myers Squibb Co. v. Royce Laboratories, Inc.
• Federal Cases - Tenneco Chemicals, Inc. v. William T. Burnett & Co., Inc.
• Federal Cases - Littlejohn v. BIC Corp.
• Federal Cases - FMC Corp. v. Cyprus Foote Mineral Co.
• Federal Cases - Zenith Laboratories, Inc. v. Bristol-Myers Squibb Co., BRISTOL-MYERS
• Federal Cases - Nixon v. Warner Communications, Inc
• Federal Cases - Atlas Powder Co. v. E.I. du Pont De Nemours & Co.
• Federal Cases - Morton Intern., Inc. v. Cardinal Chemical Co., s. 91-1174
• North Carolina - Travenol Laboratories, Inc. v. Turner
• Federal Cases - Martin v. Barber
• Federal Cases - Glaxo, Inc. v. Novopharm Ltd., 91-759-CIV-5-BO.
• Federal Cases - Ruckelshaus v. Monsanto Company
• US - Reference Stubs - Suits by persons injured
• US - Reference Stubs - Contents and term of patent; provisional rights
• US - Reference Stubs - Patents, plant variety protection, copyrights, mask works, designs, trademarks, and unfair competition
• US - Reference Stubs - Infringement of patent
• US - Reference Stubs - Monopolizing trade a felony; penalty
• US - Reference Stubs - Supplemental jurisdiction
• US - Reference Stubs - Claim for Relief Arising under 35 U.S.C. Section 271(e)(2) or 42 U.S.C. Section 262
• US - Reference Stubs - Federal question
• US - Reference Stubs - Diversity of citizenship; amount in controversy; costs